PLANTATION, Florida, April 26, 2017, CDII, /PRNewswire/ —
CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, today announced that it has entered into a wholesale distribution agreement with a U.S.-based manufacturer of cannabidiol(CBD)-based products.
Under the agreement, CD International will market CBD products to the Chinese-speaking population and CD International will purchase CBD products at a wholesale price. The most popular products include Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD Hemp Oils, Blue CBD Crystals Isolate, Relax Extreme CBD collection, CBD Shots and quality Vape Additives.
“We are very excited to bring these premium CBD-based products, manufactured in the U.S., to the Chinese-speaking population. As CBD-based products are new in the Chinese market, we believe it is an ideal point in time to bring top-quality product lines to the Chinese market place. We are prepared to be the pioneer that can empower the health conscious Chinese population with top quality premium CBD-based supplements,” said Dr. James Wang, Chairman and CEO of CD International Enterprises.
About CD International Enterprises, Inc.:
CD International Enterprises, Inc. (OTC: CDII) is a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services. The breadth of its services allows the Company to be a one-stop-shop for international companies looking to take advantage of global market opportunities. For more information about CD International, please visit https://www.cdii.net .
In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, CD International Enterprises, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as ‘will likely result,’ ‘are expected to,’ ‘will continue,’ ‘is anticipated,’ ‘estimated,’ ‘intends,’ ‘plans,’ ‘believes’ and ‘projects’) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements.
We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2016.